LAXACIN is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Direct Rx. The primary component is Docusate Sodium; Sennosides A And B.
| Product ID | 61919-497_838584ec-1cff-b130-e053-2a91aa0a70a1 |
| NDC | 61919-497 |
| Product Type | Human Otc Drug |
| Proprietary Name | LAXACIN |
| Generic Name | Laxacin |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-03-26 |
| Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Labeler Name | DIRECT RX |
| Substance Name | DOCUSATE SODIUM; SENNOSIDES A AND B |
| Active Ingredient Strength | 50 mg/1; mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2018-03-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph not final |
| Application Number | part334 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-08-28 |
| Marketing Category | OTC monograph not final |
| Application Number | part334 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-03-26 |
| Ingredient | Strength |
|---|---|
| DOCUSATE SODIUM | 50 mg/1 |
| SPL SET ID: | 68526336-76bb-7eac-e053-2a91aa0a751e |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 45865-708 | Laxacin | Docusate sodium and sennosides |
| 50488-0901 | Laxacin | Docusate sodium and sennosides |
| 55700-930 | Laxacin | Docusate sodium and sennosides |
| 61919-497 | LAXACIN | LAXACIN |
| 68071-1549 | Laxacin | Docusate sodium and sennosides |
| 68258-4985 | Laxacin | Docusate sodium and sennosides |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() LAXACIN 86119347 4555933 Live/Registered |
Alexso, Inc. 2013-11-14 |